Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6273843 | Neuroscience | 2014 | 21 Pages |
Abstract
The molecular and cellular mechanisms, which coordinate the critical stages of brain development to reach a normal structural organization with appropriate networks, are progressively being elucidated. Experimental and clinical studies provide evidence of the occurrence of developmental alterations induced by genetic or environmental factors leading to the formation of aberrant networks associated with learning disabilities. Moreover, evidence is accumulating that suggests that also late-onset neurological disorders, even Alzheimer's disease, might be considered disorders of aberrant neural development with pathological changes that are set up at early stages of development before the appearance of the symptoms. Thus, evaluating proteins and pathways that are important in age-related neurodegeneration in the developing brain together with the characterization of mechanisms important during brain development with relevance to brain aging are of crucial importance. In the present review we focus on (1) aspects of neurogenesis with relevance to aging; (2) neurodegenerative disease (NDD)-associated proteins/pathways in the developing brain; and (3) further pathways of the developing or neurodegenerating brains that show commonalities. Elucidation of complex pathogenetic routes characterizing the earliest stage of the detrimental processes that result in pathological aging represents an essential first step toward a therapeutic intervention which is able to reverse these pathological processes and prevent the onset of the disease. Based on the shared features between pathways, we conclude that prevention of NDDs of the elderly might begin during the fetal and childhood life by providing the mothers and their children a healthy environment for the fetal and childhood development.
Keywords
WntNMDAInsulin/IGF-1 signaling pathwayN-methyl-d-aspartatecdk5NGFIGF-1FCDAMPAAPPGSK3βTDP-43TSCMCDNSCApoER2Aβ precursor proteinSAPPNDDSDR6Dab1PrPcIISAβmTORBDNFVLDLRALPamyloid-βα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidHumanAlzheimer’s diseaseNeurodegenerative diseasesParkinson’s diseaselong-term potentiationLTPNeurodegenerationShhfocal cortical dysplasiaDevelopmentNeural stem cellDown syndromeubiquitin–proteasome systemcyclin-dependent kinase 5sonic hedgehogMalformation of cortical developmentDisabled-1Vascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)nerve growth factorinsulin-like growth factor 1Brain-derived neurotrophic factorCerebrospinal fluidCSFDevelopmental pathwaysBrainmammalian target of rapamycinPresenilinstar DNA-binding protein 43cellular prion proteinTuberous sclerosis complexGlycogen synthase kinase 3βApolipoprotein E receptor 2very-low-density lipoprotein receptorUPS
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
G.G. Kovacs, H. Adle-Biassette, I. Milenkovic, S. Cipriani, J. van Scheppingen, E. Aronica,